Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 2/20 | 0.37 |
| ▸ | FNTA | P49354 | 2/20 | 0.37 |
| ▸ | FNTB | P49356 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | SOAT1 | P35610 | 5/20 | 0.34 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.34 |
| ▸ | GRM5 | P41594 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9000673 | 0.95 | SOAT1 (0.37) | EPHX1SOAT1GRM5 | |
| SCHEMBL9000579 | 0.93 | KMT2A (0.35) | EPHX1FNTAFNTBSOAT1 | |
| SCHEMBL9000588 | 0.90 | EPHX1 (0.38) | EPHX1ALDH1A1SOAT1GRM5 | |
| SCHEMBL9000613 | 0.90 | LMNA (0.36) | EPHX1FNTAFNTBHPGDSOAT1 | |
| SCHEMBL9000727 | 0.86 | SOAT1 (0.40) | FNTAFNTBSOAT1 | |
| SCHEMBL9000651 | 0.85 | SOAT1 (0.41) | EPHX1ALDH1A1SOAT1 | |
| SCHEMBL9000608 | 0.85 | FNTA (0.37) | EPHX1FNTAFNTBHPGDSOAT1 | |
| SCHEMBL9000398 | 0.83 | EPHX1 (0.47) | EPHX1SOAT1 | |
| SCHEMBL9000692 | 0.82 | SOAT1 (0.46) | SOAT1 | |
| SCHEMBL9000825 | 0.81 | GLI1 (0.39) | SOAT1GRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5583147-A | INHIBITORS OF ACYL-COENZYME A: CHOLESTEROL O-TRANSFERASE; ANTIHYPERCHOLESTEROLEMIC AND/OR ANTIATHEROSCLEROTIC AGENTS | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-12-10 | — | — | US | disclosed |